Literature DB >> 9450179

Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.

M Decruyenaere1, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe.   

Abstract

Subjective risk perception, perceived impact of Huntington's disease (HD), perceived benefits and barriers of predictive testing and personality characteristics of persons withdrawing from the predictive test programme for HD and of siblings of test applicants were studied in a mailed survey. The belief that important decisions do not need to depend on a test result and the anticipated inability to cope with a bad result played an important role in the decision not to be tested. Nevertheless half of the group who ever considered testing, still planned to undergo a test in the future. A comparison of tested and untested persons revealed that the first group is more likely to overestimate the risk than the second group, but that both groups did not significantly differ from each other regarding anxiety, ego strength and coping strategies. An intrafamilial analysis of tested and untested siblings confirmed these findings. The problems during data collection and the reasons for the dropout are an illustration of the avoidant behaviour regarding HD and the predictive test in many individuals and families.

Entities:  

Keywords:  Belgium; Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1997        PMID: 9450179

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  9 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

Authors:  M Decruyenaere; G Evers-Kiebooms; A Boogaerts; J J Cassiman; T Cloostermans; K Demyttenaere; R Dom; J P Fryns
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

3.  The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.

Authors:  Luísa Rolim; José A Zagalo-Cardoso; Constança Paúl; Jorge Sequeiros; Manuela Fleming
Journal:  J Genet Couns       Date:  2006-09-27       Impact factor: 2.537

4.  Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease.

Authors:  Álvaro Mendes; Milena Paneque; Angus Clarke; Jorge Sequeiros
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

Review 5.  The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature.

Authors:  S Crozier; N Robertson; M Dale
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

6.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

7.  Fear of health insurance loss among individuals at risk for Huntington disease.

Authors:  Emily Oster; E Ray Dorsey; Jan Bausch; Aileen Shinaman; Elise Kayson; David Oakes; Ira Shoulson; Kimberly Quaid
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

8.  Making the decision to participate in predictive genetic testing for arrhythmogenic right ventricular cardiomyopathy.

Authors:  April Manuel; Fern Brunger
Journal:  J Genet Couns       Date:  2014-07-01       Impact factor: 2.537

9.  Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington's disease, Machado-Joseph disease, and familial amyloid polyneuropathy.

Authors:  Susana Lêdo; Ângela Leite; Teresa Souto; Maria A Dinis; Jorge Sequeiros
Journal:  Braz J Psychiatry       Date:  2016-02-05       Impact factor: 2.697

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.